Merck logo

Merck

Last updated January 31, 2026
124
Innovation Areas
5,362
Inventors
47
Collaborations

Insufficient viral neutralization potency: MerckRecent Research Landscape

Insufficient binding affinity and rapid viral escape from existing immune responses. Overcoming this limitation ensures sustained protection against respiratory syncytial virus infection.